|
About the company |
About Amgen
Amgen (NASDAQ: AMGN) discovers, develops and delivers
innovative human therapeutics. A biotechnology pioneer
since 1980, Amgen was one of the first companies to
realize the new science’s promise by bringing novel
medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of
medicine, helping millions of people in the fight
against cancer, kidney disease, rheumatoid arthritis,
and other serious illnesses.
Amgen has headquarters in Southern California, with
15,000 staff members in 31 countries worldwide. With a
deep and broad pipeline of potential new medicines, and
a scientific approach that unites the best of cellular
and molecular biology and medicinal chemistry, Amgen is
committed to dramatically improving people’s lives. For
more information about our pioneering science and our
vital medicines, visit www.amgen.com. |